Bayer today announced that it will present multiple new analyses of the KERENDIA ® (finerenone) clinical trial program at the European Renal Association (ERA) 62nd Congress scientific sessions in ...

Too many people still miss heart trouble Is your heart healthy? In a 2015 study published in JAMA, eight out of 10 men and women with scarring on their heart muscle—evidence of a previous heart attack ...

Breakthroughs in tricuspid and mitral valve repair signal progress in heart treatment. BEIJING, June 3, 2025 /PRNewswire/ -- ...

Patients with COPD and established cardiovascular disease have more MACEs and seek less preventive cardiac care than patients with CVD alone.

Spontaneous coronary artery dissection (SCAD) has emerged over the last decade as an increasingly recognised cause of ...

Lucknow: Heart patients in UP will soon be able to receive timely treatment at their nearest district hospital or community ...

The findings hint at why the ABYSS trial failed to show it was safe to stop beta-blockers after an MI in stable patients.

LONDON, GREATER LONDON, UNITED KINGDOM, May 26, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts ...

The following is a summary of “Apelinergic System in the Left Ventricle Adverse Remodeling After Myocardial Infarction: A ...

Presented at EuroPCR 2025, the 10-year results of the DANAMI-3-PRIMULTI trial show how complete revascularisation cuts ...

Although the 400-person study was too small to really compare clinical outcomes, Tanigaki said a count of major adverse ...

Patients with gout living in rural vs urban areas face a significantly higher risk for MI-related hospitalization.